Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
339
datasets available to search
ShareScore release 0.9.0
Dataset results
339 results for “CML”
European CML Blast Crisis Register
ClinicalTrials.gov study NCT03869502. IPD Sharing: NO. Countries: 4. Publications: 0.
Optimization of TKIs Treatment and Quality of Life in Ph+ CML Patients ≥60 Years in Deep Molecular Response
ClinicalTrials.gov study NCT02326311. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00081874. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of 2nd Gen TKI in CML
ClinicalTrials.gov study NCT02222272. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Cancer-associated Gene Mutations in CML Treatment With TKIs by NGS
ClinicalTrials.gov study NCT04274231. IPD Sharing: YES. Countries: 1. Publications: 0.
An Exploratory Study of High-dose Glivec in Patients With CML-CP Using Molecular Endpoints
ClinicalTrials.gov study NCT01216085. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France
ClinicalTrials.gov study NCT06092879. IPD Sharing: NO. Countries: 1. Publications: 0.
The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation
ClinicalTrials.gov study NCT04233346. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP)
ClinicalTrials.gov study NCT04160546. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs.
ClinicalTrials.gov study NCT05311943. IPD Sharing: NO. Countries: 1. Publications: 0.
Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population
ClinicalTrials.gov study NCT02363868. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment-free Remission Accomplished With Dasatinib in Patients With CML
ClinicalTrials.gov study NCT02268370. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment
ClinicalTrials.gov study NCT07188428. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML
ClinicalTrials.gov study NCT06757855. IPD Sharing: NO. Countries: 1. Publications: 0.
Condition Vasoregulation Function Endothelium in Patients With CML Getting TKI II Generation Bosutinib
ClinicalTrials.gov study NCT05682924. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec
ClinicalTrials.gov study NCT00250042. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Efficacy and Safety of Glinib in Newly Diagnosed CML Patients
ClinicalTrials.gov study NCT02204722. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Assessment of a Multipeptide-gene Vaccine in CML
ClinicalTrials.gov study NCT00455221. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)
ClinicalTrials.gov study NCT01011998. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparative Evaluation of Results of Allogeneic Hematopoietic Stem Cells Versus Ponatinib in CML Patients Carrying a Mutation T315I
ClinicalTrials.gov study NCT02981784. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.